Literature DB >> 7241891

Aluminum removal by hemodialysis.

H Graf, H K Stummvoll, V Meisinger, J Kovarik, A Wolf, W F Pinggera.   

Abstract

Aluminum kinetics were studied in 24 patients on chronic hemodialysis. All patients had elevated predialytic serum concentrations of aluminum (mean, 3.44 mumoles/liter), which correlated significantly with the ingestion of aluminum hydroxide (P less than 0.01). Simultaneous measurements of aluminum in plasma and ultrafiltrate revealed an ultrafiltrability of about 20% of total plasma aluminum, thus suggesting that 80% of aluminum is protein bound. When a dialysate with a very low aluminum content (varying from 0.1 to 0.3 mumoles/liter) was used, mean values across the dialyzer were 3.20 and 2.67 mumoles/liter, respectively, showing a significant decrease of plasma aluminum during dialyzer passage (P less than 0.0001). It could be shown that dialysance of aluminum depends on the concentration gradient between the free diffusible plasma aluminum and the dialysate aluminum concentration. After 6 hours of dialysis, plasma aluminum concentrations were significantly lower than were predialysis values (P less than 0.0001). We conclude that a negative aluminum balance during hemodialysis can be assumed as long as the aluminum concentration of free diffusible plasma aluminum lies above the aluminum concentration of the dialysate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7241891     DOI: 10.1038/ki.1981.56

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

1.  Aluminum transport and dialysance during haemodialysis.

Authors:  S Hosokawa; H Nishitani; T Nishio; T Imai; Y Tomita; T Tomoyoshi; K Sawanishi; O Yoshida
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 2.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

3.  Aluminum and the pathogenesis of dialysis dementia.

Authors:  A I Arieff
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

4.  Prophylactic aluminium hydroxide and hyperaluminaemia in intensive care.

Authors:  H Graf
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

5.  Determination by flameless atomic absorption of aluminium in serum and hair for toxicological monitoring of patients on chronic intermittent haemodialysis.

Authors:  H J De Groot; E J De Haas; P D'Haese; A Heyndrickx; F A De Wolff
Journal:  Pharm Weekbl Sci       Date:  1984-02-24

6.  Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.

Authors:  I S Parkinson; M K Ward; D N Kerr
Journal:  J Clin Pathol       Date:  1981-11       Impact factor: 3.411

Review 7.  Aluminum transfer during dialysis: a systematic review.

Authors:  Joëlle Mardini; Valery Lavergne; Marc Ghannoum
Journal:  Int Urol Nephrol       Date:  2014-06-18       Impact factor: 2.370

8.  Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?

Authors:  David W Mudge; David W Johnson; Carmel M Hawley; Scott B Campbell; Nicole M Isbel; Carolyn L van Eps; James J B Petrie
Journal:  BMC Nephrol       Date:  2011-05-13       Impact factor: 2.388

Review 9.  Metabolism and possible health effects of aluminum.

Authors:  P O Ganrot
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.